Answer
Caution is recommended when driving or operating machinery during imatinib treatment because patients may experience dizziness, blurred vision or somnolence.
Sources for this answer
- GLIVEC film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 41Document updated
Sources checked